Some leaders of the many sprawling agencies and centers that make up the Department of Health and Human Services have ...

The Food and Drug Administration is investigating two new Salmonella outbreaks of unknown origin. Both of the outbreaks are from Salmonella Enteritidis. One has sickened 50 people while 22 ...

The FDA’s Breakthrough Device Designation is awarded to medical technologies that offer more effective diagnosis of life-threatening or irreversibly debilitating diseases and that represent a ...

The goal is to replace them with natural alternatives in the U.S. food supply. The FDA will be accelerating the review and approval of some new natural color additives, FDA Commissioner Marty ...

The Food and Drug Administration is suspending a quality control program for its food testing laboratories as a result of staff cuts at the Department of Health and Human Services, according to an ...

On April 22, the Food and Drug Administration (FDA) announced its plan to phase out petroleum-based synthetic dyes from the U.S.’s food supply. The move is part of Health and Human Services ...

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed. Recent ...

WASHINGTON — Novavax's closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday. The news ...

Equillium (EQ) announced that the company has received feedback from its Type D meeting with the FDA to discuss the regulatory pathway for accelerated approval, as well as the company’s filing ...

The FDA is working with the food industry to eliminate petroleum-based artificial dyes from the U.S. food supply by late 2026. In their place, four new natural dyes will be authorized.

Health and Human Services Secretary Robert F. Kennedy Jr. wants companies to voluntarily remove or replace commonly used synthetic colors before the end of 2026.

Novavax aims to convert emergency authorization to full approval FDA's request boosts Novavax shares by 18% Analysts confident in Novavax's approval despite past hurdles April 23 (Reuters ...